Associate Professor | University of Tabuk | Saudi Arabia
Dr. Kousalya Prabahar is an Associate Professor in the Department of Pharmacy Practice at the University of Tabuk, Saudi Arabia. With over 19 years of experience in pharmaceutical education and research, she has established a reputation for her innovative contributions to the field. Her expertise spans various aspects of pharmaceutical care, including drug delivery systems, anti-inflammatory therapies, and antimicrobial resistance. Dr. Prabahar’s dedication to advancing pharmaceutical sciences is evident through her impactful research and teaching.
Profile
Google Scholar
Strengths for the Award
- Diverse Research Topics: Dr. Prabahar’s research spans a wide range of topics within pharmaceutical care, from anti-inflammatory and anti-arthritic activities to drug delivery systems and antimicrobial resistance. This demonstrates a broad expertise and adaptability in addressing various challenges in pharmaceutical sciences.
- High-Impact Publications: The researcher has published in reputable journals such as Experimental Gerontology, Biomedicine & Pharmacotherapy, and Scientific Reports. These publications indicate that her work is well-regarded and influential within the field.
- Innovative Contributions: Dr. Prabahar has made significant contributions to novel drug delivery systems, such as microneedle-mediated transdermal delivery and solid lipid nanoparticles for drug alleviation. These innovations highlight her ability to advance pharmaceutical technologies.
- Systematic Reviews and Meta-Analyses: Her involvement in systematic reviews and meta-analyses, such as the effects of vitamin D and tamoxifen on lipid profiles, reflects a strong ability to synthesize existing research and provide comprehensive insights.
- International and Collaborative Impact: The breadth of co-authors and collaborative work, including contributions to international journals and multi-country studies, suggests a strong network and collaborative approach in her research.
Areas for Improvement
- Interdisciplinary Integration: While Dr. Prabahar’s work is diverse, there may be opportunities to further integrate interdisciplinary approaches, combining insights from fields such as bioinformatics, molecular biology, or health economics to enhance the impact of her research.
- Emerging Technologies: There is potential for further exploration into cutting-edge technologies such as artificial intelligence in drug discovery, personalized medicine, or advanced biomaterials. Embracing these emerging trends could keep her research at the forefront of pharmaceutical care.
- Focus on Clinical Outcomes: Although many studies are highly technical, there could be a stronger emphasis on direct clinical outcomes and patient-centered research. Enhancing this aspect could increase the practical applications and relevance of her findings in clinical settings.
- Increased Engagement in Public Health: While her research touches on various health aspects, further engagement in public health initiatives, such as health policy or community-based interventions, could broaden the scope and societal impact of her work.
Education
Dr. Prabahar earned her Ph.D. in Pharmacy Practice from Sri Ramachandra University, Chennai, Tamil Nadu, India, in 2013. Prior to that, she completed her M.Pharm in Pharmacy Practice at Annamalai University, Chidambaram, Tamil Nadu, India, in 2005. Her foundational education includes a B.Pharm from Periyar College of Pharmaceutical Sciences, Trichy, affiliated with The Tamil Nadu Dr. M.G.R. Medical University, Chennai, Tamil Nadu, India, completed in 2002.
Experience
Dr. Prabahar has an extensive academic career, currently serving as an Associate Professor at the University of Tabuk since June 2022. Previously, she was an Assistant Professor at the same institution from November 2015 to June 2022. Her earlier roles include Associate Professor and Head at Vels University and positions at Jaya College of Pharmacy and Sri Ramachandra University. She began her career as a Lecturer at S.R.M. College of Pharmacy.
Research Interests
Dr. Prabahar’s research interests are diverse and include drug delivery systems, anti-inflammatory and anti-arthritic therapies, antimicrobial resistance, and systematic reviews of pharmaceutical interventions. Her work focuses on developing innovative therapeutic strategies and enhancing patient care through advanced pharmaceutical practices.
Awards
Dr. Prabahar has been recognized for her research excellence and contributions to the field of pharmaceutical care. Her awards reflect her dedication to advancing pharmaceutical science and her ability to deliver impactful research outcomes. Her work in drug delivery systems and systematic reviews has been particularly notable.
Publications
The effect of vitamin D on the lipid profile as a risk factor for coronary heart disease in postmenopausal women: A meta-analysis and systematic review of randomized controlled trials
Experimental Gerontology (2022)
Cited by: 41
In-vitro anti-inflammatory and anti-arthritic activity of leaves of Cleodendron inerme
Journal of Advanced Pharmaceutical Technology & Research (2011)
Cited by: 41
Antimicrobial resistance of bacterial agents of the upper respiratory tract in South Indian population
Journal of Advanced Pharmaceutical Technology & Research (2010)
Cited by: 37
Selenium nanoparticles prevents lead acetate-induced hypothyroidism and oxidative damage of thyroid tissues in male rats through modulation of selenoenzymes and suppression of oxidative stress
Biomedicine & Pharmacotherapy (2018)
Cited by: 36
Preparation and Evaluation of Carbamazepine Solid Lipid Nanoparticle for Alleviating Seizure Activity in Pentylenetetrazole-Kindled Mice
Molecules (2019)
Cited by: 35
Thymoquinone therapy remediates elevated brain tissue inflammatory mediators induced by chronic administration of food preservatives
Scientific Reports (2019)
Cited by: 33
Optimization of thiolated chitosan nanoparticles for the enhancement of in vivo hypoglycemic efficacy of sitagliptin in streptozotocin-induced diabetic rats
Pharmaceutics (2020)
Cited by: 30
Drug usage evaluation of dapsone
Indian Journal of Pharmaceutical Sciences (2009)
Cited by: 30
Drug utilization evaluation of third generation cephalosporins using core drug use indicators
Pak J Pharm Sci (2012)
Cited by: 26
Study on non-adherence and the effect of counseling in the pharmacological management of psychiatric patients
International Journal of Pharma and Bio Sciences (2012)
Cited by: 24
The effect of tamoxifen on the lipid profile in women: A systematic review and meta-analysis of randomized controlled trials
Experimental Gerontology (2022)
Cited by: 19
Social support, self-care behaviour and self-efficacy in patients with Type 2 diabetes during the COVID-19 pandemic: A cross-sectional study
Healthcare (2021)
Cited by: 18
Microneedle mediated transdermal delivery of β-sitosterol loaded nanostructured lipid nanoparticles for androgenic alopecia
Drug Delivery (2022)
Cited by: 17
Antibiotics Utilization Pattern in Pediatrics in a Tertiary Care Teaching Hospital
Asian Journal of Pharmaceutics (2017)
Cited by: 16
Prescribing trend of antihypertensive drugs in hypertensive and diabetic hypertensive patients
Asian Journal of Pharmaceutical and Clinical Research (2012)
Cited by: 15
Knowledge, attitude and practice of health care practitioners in Saudi Arabia, with regard to prevention of vitamin D deficiency in infancy
Saudi Medical Journal (2018)
Cited by: 14
Targeted drug delivery system: Advantages, carriers and strategies
Indian Journal of Pharmaceutical Education and Research (2021)
Cited by: 13
A prospective interventional study of knowledge, attitude and practice (KAP) towards tuberculosis among patients with Koch’s disease
Alcohol (2016)
Cited by: 13
Depression, anxiety and stress among infertile women and the impact of counseling on these levels
Innovative Journal of Medical and Health Sciences (2013)
Cited by: 13
Evaluation of Health Care Professionals’ Knowledge, Attitudes, and Practice to Prevent the Pandemic Spread of COVID-19: A Questionnaire-Based Cross-Sectional Study from Abha
Healthcare (2023)
Cited by: 12
Conclusion
Dr. Kousalya Prabahar is a highly accomplished researcher with a robust portfolio of impactful and innovative studies in pharmaceutical care. Her work demonstrates a commendable breadth of expertise and a significant contribution to advancing pharmaceutical science. The strengths of her research, particularly in innovative drug delivery systems and systematic reviews, align well with the criteria for the Best Researcher Award.
To further enhance her candidacy, focusing on interdisciplinary integration, emerging technologies, clinical outcomes, and public health engagement could amplify her impact and relevance. Overall, Dr. Prabahar’s achievements and ongoing contributions make her a strong contender for the Best Researcher Award.